Abstract submission closed on Thursday 7 September 17:00 pm (GMT+1).
NOTE: Abstract submission does not automatically comprise conference registration. Presenting authors and other authors intending to attend the conference are are required to register seperately. Click here to register.
- Abstracts can only be submitted online via the conference website; submissions by fax, post or e-mail will not be considered.
- Abstracts must be written in English.
- The abstract text body is limited to a maximum of 400 words. Titles are limited to 30 words. A maximum of one table and one graph/image (in JPG, GIF, TIFF or PNG with ideally 600 dpi and a maximum of 10 MB) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups.
- Abstracts should be structured and include concise statements outlining:
- Background – study objectives, hypothesis to be tested, or description of the problem
- Methods – method(s) used or approach taken
- Results – present as clearly and as much in detail as possible the findings/outcome of the study. Please summarise any specific results ( incl. statistical analysis when appropriate)
- Conclusion – description of the main outcome of the study, and explain the significance of your findings, and future implications of the results.
- It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
- The abstract theme is the general heading under which your abstract will be reviewed. Please choose the theme which best suits the subject of your abstract: Pathogenesis, Epidemiology, Treatment, or Prevention.
If you have any questions regarding your abstract submission, please contact the registration office at firstname.lastname@example.org, phone +31 20 57273 15.
Deadline for abstract submission
Abstracts submission closed Thursday 7 September 2017, 17:00 pm (GMT+1). Abstracts submitted after this time will not be considered.
Notification of acceptance or rejection
Notification of acceptance or rejection will be sent to the presenting author by mid October 2016. Please note that the presenting author, who will receive correspondence concerning the abstract, is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.
Abstract blinding and review
All submitted abstracts go through a blinded peer-review process carried out by selected expert reviewers.
Maximum number of abstracts
Each presenting author may present a maximum of two abstracts at the conference.
All NCHIV participants will receive the abstract book, which includes all accepted abstracts and the final programme. The abstract book will also be published on the NCHIV website. In addition, all oral and poster presentations will be published on the NCHIV website, providing author approval has been granted.
Abstract award: Joep Lange and Jacqueline van Tongeren Junior Investigator’s Award
This year the scientific programme committee will once again select the best abstract submitted by a junior scientist to be awarded the Joep Lange & Jacqueline van Tongeren Junior Investigator’s Award.
To be considered for the award, authors must be in the process of gaining or have recently gained their PhD. In addition, the abstract must relate to work carried out in gaining their PhD.
The winning abstract author will be given the opportunity to present their abstract as an oral presentation during one of the conference sessions. They will also receive a prize to the value of €1000 to be spent on a study or conference trip of their choice.
The winning author will be announced during the final conference session.
Presenting authors are also required to register separately for the conference. Registration opens on 8 May 2017.